According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

SION-2851 is under development for the treatment of cystic fibrosis. It is a small molecule administered orally. It is a first generation corrector. The drug candidate targets cystic fibrosis ...

Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

LCI proves valuable in monitoring ETI therapy effectiveness for cystic fibrosis patients with minimal FEV1 changes, detecting ...

Coughing is a natural reflex action that helps clear the airways of irritants, mucus, smoke, dust, or allergens. While most ...

Living with chronic illness in the family is hard. It's even harder if you know that the person you love will get worse and ...

Sophie Pierce is determined to make the most of her life - however long she may have.

We recently compiled a list of the 12 Best Multibagger Stocks to Buy Right Now. In this article, we are going to take a look ...

In this article, we will discuss the 12 Best Multibagger Stocks to Buy Right Now. The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs. Much of this optimism ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Tv Therapeutics Inc. (NASDAQ:VTVT – Get Free Report) was the target of a significant decline in short interest in the month ...